Delivery Order SPE2DB25D3005-SPE2DB25FQHPP
Award Date 8/5/25
Potential Completion Date 8/26/25
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ryanodex 250 mg vials valued at $9,632.64. This firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is listed as...
- This is a $4,468.92 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 250mg vials of the pharmaceutical product Ryanodex, with a period of performance through October 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply medical commodities and prescription drugs to various military treatment facilities, veterans'...
- On July 24, 2025, the Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $4,816.32 to AmerisourceBergen Drug Corp for Ryanodex 250mg vials. This firm fixed-price, non-set-aside delivery order is scheduled for completion by August 13, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ryanodex 250mg vials with a firm fixed price ceiling value of $57,795.84 and an ultimate completion date of August 18, 2025. This is a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor with an...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $52,979.52 on July 25, 2025, for the supply of Ryanodex 250mg vials. This firm fixed-price contract, which has an ultimate completion date of August 14, 2025, was awarded without a set-aside designation through competitive procurement by the Defense Logistics Agency's Medical Supply Chain. The contract represents a child delivery order under...
- The Defense Logistics Agency awarded a $3,210.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ryanodex 250 mg vials, with an ultimate completion date of August 13, 2025. This non-set-aside contract was competitively awarded on July 23, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. Ryanodex is a dantrolene sodium formulation used primarily for the acute treatment of malignant hyperthermia in surgical settings, representing a critical...
- This contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the delivery of Ryanodex 250 mg vials, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The award has a ceiling value of $5,958.56 and an ultimate completion date of October 8, 2024. This contract is not set aside for any specific business type. AmerisourceBergen, as a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 1, 2025, for the supply of Ryanodex 250mg vials valued at $61,006.72. The contract, which is not set-aside and competitively awarded, carries a firm fixed price structure with an ultimate completion date of August 21, 2025. This delivery order falls under the Medical Supply Chain division of the Department of Defense, reflecting the contractor's...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,605.44 firm-fixed-price delivery order is for the supply of RYANODEX 250MG VIAL 1S, a medical product, with a period of performance ending on January 29, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, valued at $3,210.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a medical product. The contract has a completion date of March 26, 2025 and utilizes a Firm Fixed Price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...